Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation (Q41284926)

29 September 2017

Anti-inflammatory activity of human IgA antibodies and their Fab alpha fragments: inhibition of IgG-mediated complement activation (English)

1 reference

29 September 2017

0 references

1 reference

3

1 reference

29 September 2017

Russell MW

1

1 reference

PubMed ID

2606139

29 September 2017

Reinholdt J

series ordinal

2

1 reference

PubMed ID

2606139

29 September 2017

language of work or name

English

0 references

publication date

1 December 1989

1 reference

European Journal of Immunology

29 September 2017

1 reference

29 September 2017

19

1 reference

29 September 2017

12

1 reference

29 September 2017

2243-2249

1 reference

Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense?

29 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

Interference of IgA Protease with the Effect of Secretory IgA on Adherence of Oral Streptococci to Saliva-coated Hydroxyapatite

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Aggregation and Adherence of Streptococcus sanguis : Role of Human Salivary Immunoglobulin A

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

The IgA1 proteases of pathogenic bacteria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

C1q binding and C1q deviation assays using enzyme labelled C1q

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

[3] Immunoglobulin A (IgA)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Complement Fixation on Cell Surfaces by 19 S and 7 S Antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

The binding site for C1q on IgG

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

The human IgA system: a reassessment.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

The interactions of human complement with interfacially aggregated preparations of human secretory IgA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Activation of the alternative pathway of complement by human serum IgA.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Complement-mediated solubilization of rat IgA immune precipitates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Rat C3 conversion by rat anti-2,4,dinitrophenyl (DNP) hapten IgA immune precipitates

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Failure of IgA cold agglutinin to activate C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

The ability of IgA to inhibit the complement-mediated lysis of target red blood cells sensitized with IgG antibody

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Inhibition of Cutaneous Anaphylaxis and Arthus Reactions in the Mouse by Antigen-Specific IgA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

BLOCKING OF PRAUSNITZ-KUESTNER SENSITIZATION WITH REAGIN BY NORMAL HUMAN BETA-2A GLOBULIN

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

IgA as a blocking factor in human malignant melanoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Inhibition of natural killer cell activity by IgA

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Suppression of leukocyte chemotaxis by human IgA myeloma components

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Suppression of human PMN bactericidal activity by human IgA paraproteins

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

IgA-dependent, monocyte-mediated, antibacterial activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Cytofluorographic analysis of receptors for IgA on human polymorphonuclear cells and monocytes and the correlation of receptor expression with phagocytosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

In vitro and in vivo activity of polyclonal and monoclonal human immunoglobulins G, M, and A against Pseudomonas aeruginosa lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Complement and bacteria: chemistry and biology in host defense

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Chemoattractant Receptors on Phagocytic Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Host defense against Neisseria meningitidis requires a complement-dependent bactericidal activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

The critical role of complement in experimental pneumococcal sepsis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830191210

7 January 2021

Identifiers

DOI

10.1002/EJI.1830191210

1 reference

29 September 2017

1 reference

PubMed ID

2606139